MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Sunesis Pharmaceuticals Company Profile (NASDAQ:SNSS)

Consensus Ratings for Sunesis Pharmaceuticals (NASDAQ:SNSS) (?)
Ratings Breakdown: 1 Sell Rating(s), 2 Hold Rating(s), 1 Buy Rating(s)
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: $1.67 (254.61% upside)

Analysts' Ratings History for Sunesis Pharmaceuticals (NASDAQ:SNSS)
Show:
DateFirmActionRatingPrice TargetActions
5/6/2016Cantor FitzgeraldReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/24/2015Cowen and CompanyDowngradeOutperform -> Market PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/24/2015Roth CapitalDowngradeBuy -> Sell$5.50 -> $1.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/2/2015WedbushReiterated RatingHold$2.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/6/2015BTIG ResearchInitiated CoverageBuy$5.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/6/2014RBC CapitalDowngradeOutperform -> Sector Perform$9.00 -> $3.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/6/2014Wells FargoDowngradeOutperform -> Market PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/26/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha